Skip to main content
          Skip to FDA Search
          Skip to in this section menu
          Skip to footer links


U.S. flagAn official website of the United States government

					Here’s how you know
          			Dot gov**The .gov means it’s official.**Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
							      SSL**The site is secure.** The **https://** ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. 
			U.S. Food and Drug Administration
				
        Search
            Menu
							
						Search FDA
									
									Submit search 
		Featured
							Contact FDA
	                FDA Guidance Documents
	                Recalls, Market Withdrawals and Safety Alerts
	                Press Announcements
	                Warning Letters
	                Advisory Committees
	                En Español

					Products
            Food
							Drugs
							Medical Devices
							Radiation-Emitting Products
							Vaccines, Blood, and Biologics
							Animal and Veterinary
							Cosmetics
							Tobacco ProductsTopics
            About FDA
							Combination Products
							Regulatory Information
							Safety
							Emergency Preparedness
							International Programs
							News and Events
							Training and Continuing Education
							Inspections and Compliance
							Science and ResearchInformation For
            Consumers
	            Patients
	            Industry
	            Health Professionals
	            Federal, State and Local Officials 
 In this section:

                FDA Meetings, Conferences and Workshops

FDA Meetings, Conferences and Workshops

                        FDA Meetings, Conferences, and Workshops: Past Events
          FDA Annual Reports on Conferences


                        Public Calendar - Meetings With FDA Officials Home
          News & Events
          FDA Meetings, Conferences and Workshops
          Second Annual FDA ASCO WORKSHOP on Getting the Dosage Right SEPTEMBER 6-7, 2023 - 09/06/2023FDA Meetings, Conferences and Workshops Virtual
    Event Title
              Second Annual FDA ASCO WORKSHOP on Getting the Dosage Right SEPTEMBER 6-7, 2023


                  September 6 - 7, 2023

  

             Optimizing Dosage Selection Strategies in Combination Cancer Therapies.
  
  Share
    Post
    Linkedin

    Email
    PrintOn This Page
      Meeting Information
                Event MaterialsDate:
          
  


     
                                                       
       

September 6 - 7, 2023   

 
 
        
                
                                      Day1: 
              Wed, Sep 6 1:00 PM
 - 4:45 PM
 ET
            
                      Day2: 
              Thu, Sep 7 1:00 PM
 - 4:45 PM
 ET
                
  Organized By: 
      Organizer
          Oncology Center of Excellence

 

  Twitter: #Gettingthedoseright23

Background

Over the last two years, FDA and ASCO have cosponsored several workshops that have highlighted the limitations to our current strategies for determining the recommended dosage(s) of anticancer agents for evaluation in registration trials. Specifically, discussions at the 2021 workshop on Defining a Research Agenda to Address Barriers and Solutions to Oral Anticancer Agent Adherence found that a primary barrier to adherence is poor tolerability for patients at the recommended labeled dosage. In 2022, a workshop on Getting the Dose Right: Optimizing Dose Selection Strategies in Oncology explored the research and clinical challenges for dosage optimization for anticancer therapies administered as single agents. It concluded that oncology needs a paradigm shift to optimize dosage selection for  new drugs and highlighted strategies to achieve dosage optimization in the premarket setting.

A primary challenge to dosage optimization in oncology is that dosage selection is often based on the maximum tolerated dosage or highest administered dosage, which was an approach developed for cytotoxic chemotherapies. In contrast, most anticancer agents currently in development are targeted therapies, many of which are oral drugs. Higher doses of targeted therapies may not have greater antitumor effects, and patients may stay on these therapies for long periods of time, increasing the importance of tolerability. Dosage optimization in oncology is further complicated by the use of anticancer drugs in combinations that have additive or potentially synergistic effects but also greater toxicity than when administered as monotherapies.

The FDA and American Society of Clinical Oncology (ASCO) have expressed a willingness to leverage their combined strengths for the joint development of the substantive actions of a workshop related to optimizing dosage selection in combination therapies.  Specific topics to discuss at this workshop could include:

Determining the challenges to dosage optimization for combination therapies
	Identifying nonclinical data that support dosage optimization of the combination therapy
	Assessing pharmacokinetic and pharmacodynamic interactions for dosage optimization of combination regimens
	Evaluating trial designs to support dosage optimization of combination therapiesThe workshop will include four sessions and will be fully virtual and open to the public. Meeting registration is required using the link provided above.

Meeting Goals

Provide a forum for open discussion among academia, industry, regulatory agencies, and patient groups about optimizing the dosage of combination anticancer agents.
	Discuss how to apply nonclinical, clinical pharmacology, clinical, and statistical evaluations to optimize the dosages of combination anticancer agents.
	Discuss benefits and challenges related to pre- marketing dosage optimization trials of combination agents.
	Discuss clinician and patient factors that impact participation in pre- marketing dosage optimization trials of combination agents.Workshop Materials

Agenda
	Biographies
	Day 1
		Day 2
	Day 1 Recording
	Day 2 RecordingContacts

Caitlin Drew, MSN, RN
Senior Regulatory Health Project Manager
Oncology Center of Excellence, (OCE)
Office of the Commissioner (OC)
U.S. Food and Drug Administration
10903 New Hampshire Ave, Silver Spring, MD 20993
Tel: 301.318.8609Caitlin.Drew@fda.hhs.gov





Event Materials

  Title
            File Type/SizeUpdated_Dose Combinations Workshop Agenda PUBLIC.pdf
              pdf               (168.21 KB)Getting the Dose Right Bios Day 1, Sept. 6, 2023
              pdf               (604.64 KB)Getting the Dose Right Bios Day 2, Sept. 7, 2023
              pdf               (619.04 KB)

                                                                                  Content current as of:
      09/29/2023More Meetings,
      Conferences, and
      Workshops
        
        FDA Meetings, Conferences and Workshops

          
                        FDA Meetings, Conferences, and Workshops: Past Events
          FDA Annual Reports on Conferences


                        Public Calendar - Meetings With FDA Officials
 
 Footer Links
    FDA Archive
          About FDA
          Accessibility
      Visitor Information
          Website Policies / Privacy
          No FEAR Act
          Vulnerability Disclosure Policy
      FOIA
          HHS.gov
          USA.gov
    Contact FDA
      Follow FDA on Facebook
      Follow FDA on X
      Follow FDA on Instagram
      Follow FDA on LinkedIn
      View FDA videos on YouTube
      Subscribe to FDA RSS feeds
    FDA Homepage
    Contact Number
      1-888-INFO-FDA (1-888-463-6332) Back toTop